Search
    Skip to main content
    Advertisement

    Johnson and Johnson

    1. Industry Sectors
    2. Pharmaceuticals
    3. Johnson and Johnson
    Johnson & Johnson partner contineum slides as depression drug fails Benzinga16:16
    J&J’s Darzalex combination treatment for untreated multiple myeloma recommended by NICE PMLiVE13:05
    Johnson & Johnson's RYBREVANT® (amivantamab-vmjw) plus chemotherapy delivers longest reported… PR Newswire (Press Release)02:53
    NICE backs ibrutinib regimen for untreated mantle cell lymphoma PharmaTimes11:37
    Sandoz generic would infringe j&j unit patents, judge says Law36020:29
    J&j's RYBREVANT plus chemotherapy sets new benchmark in EGFR exon 20 insertion NSCLC survival RTT News09:24
    Apollo global is said in talks to acquire j&j’s orthopedics unit Bloomberg Law00:40

    Latest News

    In the last 2 hours
    Abiomed Gets Benefit Plan Exemption for Johnson & Johnson Deal Bloomberg Law15:13
    Yesterday
    Dow Analyst Moves: JNJ Nasdaq18:41 15-Sept-26
    Johnson & Johnson (JNJ) Reports Lower Side Effects In Advanced EGFR Lung Cancer Simply Wall St17:29 15-Sept-26
    Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick Nasdaq17:20 15-Sept-26
    Johnson & Johnson Partner Contineum Slides as Depression Drug Fails Benzinga16:16 15-Sept-26
    Dow Movers: JNJ, HONIV Nasdaq15:38 15-Sept-26
    New support helps strengthen American Red Cross disaster preparedness and response American Red Cross (Press Release)15:32 15-Sept-26
    Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It Zacks15:10 15-Sept-26
    J&J’s Darzalex combination treatment for untreated multiple myeloma recommended by NICE PMLiVE13:05 15-Sept-26
    NICE backs daratumumab quadruplet for transplant‑eligible myeloma PharmaTimes10:23 15-Sept-26
    Rybrevant Faspro™ (amivantamab and hyaluronidase-lpuj) plus Lazcluze® (lazertinib) with… PR Newswire (Press Release)04:03 15-Sept-26
    In the last 7 days
    Johnson & Johnson requires providers to share claims data to get 340B discounts Healthcare Dive22:06 14-Sept-26
    Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/pipe-307 for the Treatment of Major … Business Wire (Press Release)21:12 14-Sept-26
    Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio Zacks17:46 14-Sept-26
    Here's My Pick for the Smartest High-Yield Dividend Stock to Buy Right Now The Motley Fool16:58 14-Sept-26
    Apollo rumoured to be eyeing $20bn takeover of J&J’s orthopaedics business Verdict Medical Devices16:50 14-Sept-26
    J&J’s Rybrevant linked to longest median OS in exon 20 EGFR NSCLC Clinical Trials Arena16:47 14-Sept-26
    Amivantamab regimen delivers longest survival in EGFR Ex20ins lung cancer PharmaTimes10:31 14-Sept-26
    Zacks Investment Ideas feature highlights: Johnson & Johnson, Coca-Cola and Exxon Mobil Zacks10:06 14-Sept-26
    J&J's Rybrevant Plus Chemotherapy Sets New Benchmark In EGFR Exon 20 Insertion Nsclc Survival RTT News09:24 14-Sept-26
    Johnson & Johnson's Rybrevant® (amivantamab-vmjw) plus chemotherapy delivers longest reported… PR Newswire (Press Release)02:53 14-Sept-26
    2 Outstanding Dividend Stocks to Buy and Hold for 10 Years The Motley Fool08:31 12-Sept-26
    Apollo Global Is Said in Talks to Acquire J&J’s Orthopedics Unit Bloomberg Law00:40 12-Sept-26
    Jaguar Laa, Inc. Announces Acquisition of Assets Related to the Laminar Program PR Newswire (Press Release)20:39 11-Sept-26
    J&J’s new reusable contact lens secures CE Mark Verdict Medical Devices10:23 11-Sept-26
    Johnson & Johnson Receives Ce Marking For Acuvue Oasys Max 2-Week Contact Lenses RTT News14:16 10-Sept-26
    Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses Business Wire (Press Release)12:48 10-Sept-26
    NICE backs ibrutinib regimen for untreated mantle cell lymphoma PharmaTimes11:37 10-Sept-26
    [Global Pharma Leadership Voices] Innovation can’t wait: getting new medicines to patients faster Korea Biomedical Review01:33 10-Sept-26
    Sandoz Generic Would Infringe J&J Unit Patents, Judge Says Law36020:29 9-Sept-26
    In the last month
    Johnson & Johnson spotlights new neuropsychiatry data across bipolar mania, depression and… PR Newswire (Press Release)13:05 8-Sept-26
    Does IMAAVY’s Approval and Ongoing Talc Verdict Meaningfully Shift the Bull Case for Johnson & Johnson (JNJ)? Simply Wall St21:28 6-Sept-26
    Johnson & Johnson Reaches Analyst Target Price Nasdaq12:35 4-Sept-26
    Johnson & Johnson (JNJ) Could Be 24% Below Fair Value On FDA Approval News Simply Wall St21:21 3-Sept-26
    AbbVie could take BiTE of Tecvayli market share on Phase III MM win Clinical Trials Arena14:56 3-Sept-26
    Alphabet, Micron ramp up FX hedging Risk.net12:51 3-Sept-26
    Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit Business Wire (Press Release)21:29 2-Sept-26
    Notable ETF Inflow Detected - IWD, BRK.B, XOM, JNJ Nasdaq16:23 2-Sept-26
    Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts Zacks23:49 1-Sept-26
    Texas asks Fifth Circuit to force J&J to pay for Tylenol court shuffle Courthouse News19:40 1-Sept-26
    Linklaters Welcomes J&J Litigation VP In New York Law36018:01 1-Sept-26
    Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli Simply Wall St17:20 1-Sept-26
    Linklaters lures Johnson & Johnson litigation head in New York The Lawyer12:01 1-Sept-26
    Linklaters Nabs J&J’s Mass Tort Legal Strategist VP Erik Haas Bloomberg Law11:00 1-Sept-26
    Defamation Litigation Roundup: NYT, J&J, Azerbaijan Law36003:45 1-Sept-26
    Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results Business Wire (Press Release)22:14 31-Aug-26
    On the Move: J&J's Hartgrove Drives to Stellantis O'Dwyer's PR Daily21:02 31-Aug-26
    Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch. The Motley Fool10:11 31-Aug-26
    AbbVie vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool18:41 29-Aug-26
    Johnson & Johnson Stock: Is JNJ Outperforming the Consumer Staples Sector? Barchart18:18 29-Aug-26
    Forget Nvidia. Johnson & Johnson and 2 Other AI Stocks Are Beating the Market by 29 Points. Barchart00:10 29-Aug-26
    THE FAX SPEAK FOR THEMSELVES: Third Circuit Revives TCPA Class Action Against J&J and Holds a “Patient Support” Fax Can … JD Supra20:09 28-Aug-26
    Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy? Zacks17:45 28-Aug-26
    Warren Buffett Thinks Investors Are "Gambling" Right Now. Here are 2 Stocks That Should Be Safe Bets. The Motley Fool15:13 28-Aug-26
    China approves J&J psoriasis pill Icotyde, says drugmaker Times LIVE14:49 27-Aug-26
    The Zacks Analyst Blog Highlights JPMorgan, Johnson & Johnson, Mastercard and Comstock Zacks11:01 27-Aug-26
    Johnson & Johnson Just Got a Big FDA Win The Motley Fool06:49 27-Aug-26
    Top Analyst Reports for JPMorgan, Johnson & Johnson & Mastercard Zacks00:26 27-Aug-26
    Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know Zacks23:45 26-Aug-26
    I Think Johnson & Johnson Is the Best Dividend Stock to Buy Right Now The Motley Fool20:39 26-Aug-26
    SimuTech Group Engineers Co-Author Chapter in Open-Access Medical Device Vvuq Handbook PR Newswire (Press Release)15:51 26-Aug-26
    Johnson & Johnson (JNJ) Wins FDA Approval For First Warm Autoimmune Hemolytic Anemia Treatment Simply Wall St05:22 26-Aug-26
    J&J’s Imaavy secures expanded US approval in rare blood disorder Pharmaceutical Technology21:31 25-Aug-26
    Notable ETF Inflow Detected - USMC, V, JNJ, BRK.B Nasdaq16:13 25-Aug-26
    Expanded US Imaavy approval first ever for wAIHA pharmaphorum14:32 25-Aug-26
    Johnson & Johnson scores 1st FDA label expansion for Imaavy FiercePharma14:23 25-Aug-26
    U.S. FDA expands approval for J&J’s drug for rare blood disorder BNN Bloomberg13:27 25-Aug-26
    FDA approves Imaavy® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic… PR Newswire (Press Release)00:13 25-Aug-26
    Johnson & Johnson Announces New Global Classification System for Surgical… WebWire18:47 24-Aug-26
    Louisiana Jury Issues $10 Million Verdict in Talc-Related Mesothelioma Case Against Johnson &… Business Wire (Press Release)17:25 24-Aug-26
    Johnson & Johnson’s multiple myeloma treatment secures EC approval Pharmaceutical Technology10:06 24-Aug-26
    Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson? The Motley Fool21:18 23-Aug-26
    Three scientists beat J&J in fight over talc research Gulf News03:01 22-Aug-26
    Crystal Palace Owner Woody Johnson Buys Into Lawrence Stroll’s Aston Martin Formula 1 Team F1 Chronicle23:19 21-Aug-26
    Dow closes 500 pts higher as Wall Street rebounds from Treasury yield-driven sell-off Invezz21:23 21-Aug-26
    J&J scores EU approval for Tecvayli combo in second line pharmaphorum19:10 21-Aug-26
    Johnson & Johnson Wins FDA 510(k) Clearance for MONARCH QUEST 3 Update Zacks17:55 21-Aug-26
    Johnson & Johnson's Tecvayli-Daratumumab Combo Wins EU Approval For Relapsed Myeloma RTT News12:36 21-Aug-26
    How Investors May Respond To Madrigal (MDGL) Adding J&J R&D Leader John C. Reed To Its Board Simply Wall St04:34 21-Aug-26
    J&J Talc Unit Loses Libel Suit Over Flawed Cancer Study Law36002:25 21-Aug-26
    Johnson & Johnson (JNJ) Registers a Bigger Fall Than the Market: Important Facts to Note Zacks23:53 20-Aug-26
    Johnson & Johnson Talc Unit Loses Libel Claims Against Doctors Bloomberg Law19:30 20-Aug-26
    Johnson & Johnson Just Sent Shareholders an Important 11-Word Message About Its Future The Motley Fool16:16 20-Aug-26
    Johnson & Johnson Announces monarch™ quest 3, Advancing the Latest in… WebWire13:40 20-Aug-26
    Pro-Business Foundation Backs J&J's Stelara Antitrust Win Law36001:37 20-Aug-26
    Johnson & Johnson Publishes New Future of Digital Surgery Report to Help Define … WebWire21:29 18-Aug-26
    Notable Tuesday Option Activity: JNJ, DAL, PWR Nasdaq18:55 18-Aug-26
    November 20th Options Now Available For Johnson & Johnson (JNJ) Nasdaq15:52 18-Aug-26
    J&J secures FDA clearance for MONARCH QUEST 3 bronchoscopy system Hospital Management09:08 18-Aug-26
    What is acute myeloid leukemia? Johnson & Johnson (Press Release)12:00 17-Aug-26
    Zacks Industry Outlook Highlights Eli Lilly, Johnson & Johnson and Bayer Zacks11:53 17-Aug-26
    view more headlines
    16 Sept 15:13

    About our Johnson & Johnson news

    Latest news on Johnson & Johnson, the American multinational pharmaceutical, known for developing healthcare, pharmaceuticals, and consumer products. Stay updated on stories about their pioneering medical advancements, including vaccines, treatments, and medical devices. Explore insights into the company’s financial performance, share prices, leadership changes, and global strategies.

    Pharmaceuticals Top Stories

    Durham University spin-out lands £1.3m to accelerate commercialisation of screening platform Insider Media07:49
    Medical device industry backs Tukaram Mundhe's call for review of pricing rules Mint06:47
    Rs 11 product, Rs 325 MRP: Tukaram Mundhe flags huge hospital pricing gap India Today06:05
    New treatment option approved in Japan for rare genetic liver disorders News-Medical.Net17:34
    Agonisingly slow clinical trial is stopping Indian pharma become global innovator from supplier The Economic Times19:01

    UK Top Stories

    Village votes in symbolic referendum to leave UK in protest over migrant housing plan Anadolu Agency15:34Asylum Seekers Asylum Seekers (World) Immigration
    Tiny village votes to quit UK in protest at asylum-seeker accommodation Politico EU10:12Asylum Seekers Asylum Seekers (World) Immigration
    Search continues for missing three-year-old boy Evening Standard10:38Suffolk
    Last known movements of missing Noah Woods, 3, as first CCTV shared The Independent13:16Suffolk
    Prime suspect in ‘Putney pusher’ case found dead at his London home The Independent14:55Wandsworth London England
    'Putney pusher' suspect found dead at home BBC15:53Wandsworth London England
    Inflation has jumped to 3.1%. Here’s why and what will happen next The Independent11:53Office for National Statistics Economy Inflation
    Mapped: Where petrol is costing Britons the most The Independent10:34Office for National Statistics Economy Inflation
    Man, 57, arrested over death in suspected shooting in Armadale BBC14:38Scotland
    Arrest follows death of man in West Lothian Evening Standard14:45Scotland

    World Top Stories

    Canada to become first associate member of EU. What von der Leyen's proposal means India Today15:24Ursula von der Leyen EU Canada
    EU wants Canada as its first ‘associate member,’ von der Leyen says Global News13:35Ursula von der Leyen EU Canada
    Kosovo, Albania criticize verdict in Thaci war crimes case while France backs tribunal Anadolu Agency13:12Kosovo War Crimes Southern Europe
    Kosovo ex-President Thaci gets jailed 25 years for war crimes Kyiv Post14:49Kosovo War Crimes Southern Europe
    Sudan gold mine collapse kills at least 67 in RSF-held West Kordofan India Today16:15Sudan Precious Metals Africa
    Gold mine collapse has killed at least 67 people in a remote area in Sudan ABC News16:25Sudan Precious Metals Africa
    Trump’s envoy wins release of 25 Belarus prisoners as US drops more sanctions Times LIVE14:44Belarusian Politics Belarus US
    Belarus releases 25 political prisoners after US envoy's visit euronews13:45Belarusian Politics Belarus US
    Saudi Arabia says Houthi drone targeted Mecca, calls holy city a red line India Today14:33Islam Houthis Saudi Arabia
    Saudi says Houthi drone attack targeted Mecca amid uncertain allied support India Today12:21Islam Houthis Saudi Arabia
    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.